The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy management

Affiliations

• ¹ Centre for Rheumatology, Division of Medicine, University College London, London, UK. Electronic address: [email protected].
• ² Chelsea and Westminster Hospital NHS Trust, London, UK.
• ³ Danish Centre for Expertise in Rheumatology (CeViG), Danish Hospital for Rheumatic Diseases, Sønderborg, Denmark; Thrombosis and Haemostasis, Guy's and St Thomas' NHS Foundation Trust, London, UK.
• ⁴ Department of Rheumatology, UCLH, London, UK.
• ⁵ Comprehensive Clinical Trials Unit, University College London, London, UK.
• ⁶ Institute of Clinical Trials and Methodology, University College London, London, UK.
• ⁷ Obstetrics and Maternal and Fetal Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
• ⁸ Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
• ⁹ Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
• ¹⁰ UCL Elizabeth Garrett Anderson Institute for Women's Health, London, UK.
• ¹¹ Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Department of Rheumatology, Royal North Shore Hospital, Sydney, NSW, Australia.
• ¹² Department of Rheumatology, Erasmus University Medical Centre, Rotterdam, Netherlands.
• ¹³ Department of Allergology, Rheumatology and Clinical Immunology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
• ¹⁴ Obstetrics and Maternal Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK; UK Teratology Information Service, Newcastle, UK.
• ¹⁵ Maternity Department, Guy's and St Thomas' Hospital, London, UK.
• ¹⁶ Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC, USA.